We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Thursday newspaper round-up: Merck, North Sea, life sciences

Thu 11 September 2025 07:24 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - The US drugmaker Merck has scrapped a £1bn London research centre and is laying off 125 scientists in the capital this year, in a big blow to the UK's important life science sector. Keir Starmer's government has described life sciences as "one of the crown jewels of the UK economy" and the previous Conservative government had vowed to turn the country into a "global science and technology superpower" by 2030. - Guardian

The chancellor, Rachel Reeves, has told private equity bosses that she plans to shut down more regulators across the UK as she attempts to drive growth across Britain's subdued economy. Reeves - who in July claimed regulators were a "boot on the neck" of business - highlighted her recent decisions to sack the chair of the competitions watchdog, shut down the payments regulator, and "severely" constrain the Financial Ombudsman Service, which UK banks have long lobbied to curtail. However, she said there was "still more to do". - Guardian

Ed Miliband must embrace the declining North Sea by offering subsidies to oil and gas companies operating in the basin, Dale Vince has said. Mr Vince, the green energy tycoon who is also a Labour donor, said companies that operate in the North Sea should be given a guaranteed minimum price per barrel of oil and gas to put them on an equal footing with renewable energy providers. - Telegraph

The UK is "losing the race" to attract global investment into its key life sciences and pharmaceutical sectors due to an uncompetitive operating environment, the pharmaceuticals industry has warned amid a stand-off with the government. The critical report from the Association of the British Pharmaceutical Industry "lays bare" the country's drop in rankings in attracting foreign direct investment and commercial clinical trials. - The Times

    Daily market update emails

    • FTSE 100 riser and faller updates
    • Breaking market news, plus the latest share research, tips and broker comments

    Register now for free market updates

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.